Speakers Jo Brewer VP, Allogeneic Research Adaptimmune Anthony Colenburg Director of Quality Adicet Bio Peter Flynn CTO Artiva Biotherapeutics Blake Aftab VP, Preclinical & Translational Science Atara Biotherapeutics Manny Duenas VP, Head of Global Market Access Atara Biotherapeutics Maksim Mamonkin Assistant Professor Baylor College of Medicine Joy Aho Senior Product Manager Be The Match BioTherapies Ian McNiece CSO Biocardia Aura Mackenzie Senior Director Bluebird Bio Robert Deans CIO Bluerock Therapeutics Katie Pollock Head of Formulation & Cryobiology Bristol-Myers Squibb Olivier Godeaux CMO Bone Therapeutics Jean-Pierre Latere COO Celyad Elizabeth Garner Principal Scientist Caribou Biosciences Luis Borges CSO Century Therapeutics Demetrios Kalaitzidis Director, ImmunoOncology CRISPR Therapeutics Bob Valamehr CDO Fate Therapeutics Oliver Nussbaumer Head of Immunology GammaDelta Therapeutics Dominic Clarke Global Head of Cell Therapy HemaCare Corporation Yannick Bulliard Director, Translational Science Immatics Lawrence Lamb CSO Incysus Therapeutics Chris Bond VP, Cellular Engineering Kite Pharma Andy Snowden Senior Director, Process Development Kite Pharma Marcos Langtry Head of Allogeneic Cell Therapy Commercial Development Lonza Pharma & Biotech Jean-François Chaubard CTO MaSTheCell Tamara Laskowski Senior Research Scientist, Immunotherapy MD Anderson Center Meisam Naeimi Postdoctoral Fellow Nationwide Children's Hospital Hans Klingemann VP, R&D NantKwest Guanglin Yu Senior Scientist Novartis Sumithira Vasu Associate Professor The Ohio State University Stacey Cranert Associate Director Poseida Therapeutics Chris Heery CMO Precision BioSciences Dan MacLeod Head of Cell Therapy Precision Biosciences Jonathan Gilbert Head of Business Development SQZ Biotechnologies Chelsea Xue Director, Head of Analytics, Cell Therapy Takeda Lan Cao Senior Director, Head of Product Development & Global Program Leader, Cell Therapy Takeda Dario Gutierrez VP, Discovery, Research & Innovation TCR2 Therapeutics Michael Leek CEO TCBiopharm Bruce Bunnell Professor & Director Tulane University of Louisiana Evren Alici CEO Vycellix Stewart Abbot CSO Adicet Bio Mark Leonard VP, Process & Product Development Allogene Therapeutics Mark Leonard
